0001104659-19-005906.txt : 20190205
0001104659-19-005906.hdr.sgml : 20190205
20190205193900
ACCESSION NUMBER: 0001104659-19-005906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Read Simon
CENTRAL INDEX KEY: 0001688199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37926
FILM NUMBER: 19569518
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
STREET 2: C/O RA PHARMACEUTICALS, INC.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001481512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262908274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 401-4060
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
a4.xml
4
X0306
4
2019-02-01
0
0001481512
Ra Pharmaceuticals, Inc.
RARX
0001688199
Read Simon
C/O RA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
BOSTON
MA
02140
0
1
0
0
Chief Scientific Officer
COMMON STOCK
2019-02-01
4
M
0
9167
A
9167
D
COMMON STOCK
2019-02-01
4
F
0
2933
21.00
D
6234
D
Options to Purchase Common Stock
21.00
2019-02-01
4
A
0
107000
0
A
2029-02-01
Common Stock
107000
107000
D
Restricted Stock Units
2019-02-01
4
M
0
9167
0
D
Common Stock
9167
18333
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
These stock options vest in 48 equal monthly installments on each monthly anniversary following February 1, 2019, the grant date.
On February 1, 2018, the reporting person was granted 27,500 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Not applicable.
/s/ David Lubner, Attorney-in-Fact for Simon Read
2019-02-05